Literature DB >> 21882075

Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?

Joanna Domagała-Kulawik1, Tomasz Skirecki, Marta Maskey-Warzechowska, Hanna Grubek-Jaworska, Ryszarda Chazan.   

Abstract

Bronchoalveolar lavage (BAL) is a useful technique for differential diagnosis of various interstitial lung diseases (ILDs) and is usually realized by analysis of the differential cell count. This study was conducted to estimate the value of bronchoalveolar lavage fluid (BALF) total cell count (TCC) in the diagnosis of ILD. We analyzed 237 BAL samples from patients with ILD: sarcoidosis (SA), idiopathic pulmonary fibrosis (IPF), cryptogenic organizing pneumonia (COP), hypersensitivity pneumonitis (HP), chronic eosinophilic pneumonia (CEP), and smoking-related ILD (sr-ILD). The control group consisted of 30 healthy volunteers. The statistical analysis revealed significant differences in the BALF TCC between healthy controls and patients with SA, IPF, HP, COP, sr-ILD, and eosinophilic disorders (mean values 6.9 vs. 14.5, 22.5, 22.8, 20.7, 64.5, and 27.3 × 10(6), respectively). Logistic regression revealed a significant relation between the TCC and ILD diagnosis. We conclude that the TCC, as well as the value of total number of inflammatory cells, should be reported in the description of BAL.

Entities:  

Mesh:

Year:  2012        PMID: 21882075     DOI: 10.1007/s10753-011-9378-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

Review 1.  Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group.

Authors: 
Journal:  Eur Respir J       Date:  1989-06       Impact factor: 16.671

2.  Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis.

Authors:  Shinichiro Ohshimo; Francesco Bonella; Ai Cui; Martin Beume; Nobuoki Kohno; Josune Guzman; Ulrich Costabel
Journal:  Am J Respir Crit Care Med       Date:  2009-02-26       Impact factor: 21.405

3.  Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Authors:  B Bradley; H M Branley; J J Egan; M S Greaves; D M Hansell; N K Harrison; N Hirani; R Hubbard; F Lake; A B Millar; W A H Wallace; A U Wells; M K Whyte; M L Wilsher
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

Review 4.  Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1990-05

Review 5.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

Review 6.  Histologic spectrum of idiopathic interstitial pneumonias.

Authors:  Daniel W Visscher; Jeffrey L Myers
Journal:  Proc Am Thorac Soc       Date:  2006-06

7.  Alterations in immunoregulatory T-cell subsets in cigarette smokers. A phenotypic analysis of bronchoalveolar and blood lymphocytes.

Authors:  U Costabel; K J Bross; C Reuter; K H Rühle; H Matthys
Journal:  Chest       Date:  1986-07       Impact factor: 9.410

8.  Flow cytometric evaluation of lymphocyte subpopulations in BALF of healthy smokers and nonsmokers.

Authors:  G Hoser; J Kawiak; J Domagała-Kulawik; P Kopiński; W Droszcz
Journal:  Folia Histochem Cytobiol       Date:  1999       Impact factor: 1.698

Review 9.  Bronchoalveolar lavage in sarcoidosis.

Authors:  Marjolein Drent; Khaled Mansour; Catharina Linssen
Journal:  Semin Respir Crit Care Med       Date:  2007-10       Impact factor: 3.119

Review 10.  Bronchoalveolar lavage in malignancy.

Authors:  Venerino Poletti; Giovanni Poletti; Bruno Murer; Luca Saragoni; Marco Chilosi
Journal:  Semin Respir Crit Care Med       Date:  2007-10       Impact factor: 3.119

View more
  10 in total

1.  Activated CD8(+) T cells and NKT cells in BAL fluid improve diagnostic accuracy in sarcoidosis.

Authors:  A Tøndell; A D Rø; A Åsberg; M Børset; T Moen; M Sue-Chu
Journal:  Lung       Date:  2013-11-10       Impact factor: 2.584

2.  Cellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with Pneumocystis jirovecii pneumonia.

Authors:  Ju Young Lee; Hyun Jung Park; Yong Kyun Kim; Shinae Yu; Yong Pil Chong; Sung-Han Kim; Heungsup Sung; Sang-Oh Lee; Mi-Na Kim; Chae-Man Lim; Yang Soo Kim; Younsuck Koh; Jun Hee Woo; Sang-Ho Choi
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

3.  Aerosolized human extracellular superoxide dismutase prevents hyperoxia-induced lung injury.

Authors:  Chih-Ching Yen; Yi-Wen Lai; Hsiao-Ling Chen; Cheng-Wei Lai; Chien-Yu Lin; Wei Chen; Yu-Ping Kuan; Wu-Huei Hsu; Chuan-Mu Chen
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

4.  In vivo evaluation of TNF-alpha in the lungs of patients affected by sarcoidosis.

Authors:  Filippo Galli; Tiziana Lanzolla; Vittorio Pietrangeli; Gaurav Malviya; Alberto Ricci; Pierdonato Bruno; Paola Ragni; Francesco Scopinaro; Salvatore Mariotta; Alberto Signore
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

5.  Macrophage polarization in interstitial lung diseases.

Authors:  Paweł Wojtan; Michał Mierzejewski; Iwona Osińska; Joanna Domagała-Kulawik
Journal:  Cent Eur J Immunol       Date:  2016-07-15       Impact factor: 2.085

6.  The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.

Authors:  Boubacar Efared; G Ebang-Atsame; Sani Rabiou; Abdoulsalam S Diarra; Layla Tahiri; Nawal Hammas; Mohamed Smahi; Bouchra Amara; Mohamed C Benjelloun; Mounia Serraj; Laila Chbani; Hinde El Fatemi
Journal:  J Negat Results Biomed       Date:  2017-03-01

7.  Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7.

Authors:  J Guiot; M Henket; J L Corhay; C Moermans; R Louis
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

8.  Correlation of bronchoalveolar lavage lymphocyte count with the extent of lung fibrosis and with plethysmographic lung volumes in patients with newly recognized hypersensitivity pneumonitis.

Authors:  Monika Szturmowicz; Inga BaraŃska; Agnieszka Skoczylas; MaŁgorzata E JĘdrych; Urszula Demkow
Journal:  Cent Eur J Immunol       Date:  2020-11-01       Impact factor: 2.085

9.  Bronchoalveolar Lavage Fluid Characteristics of Patients With Sarcoidosis and Nonsarcoidosis Interstitial Lung Diseases: Ten-Year Experience of a Single Center in Turkey.

Authors:  Hakan Tanriverdi; Fatma Erboy; Bulent Altinsoy; Firat Uygur; Mehmet Arasli; Ishak Ozel Tekin; Muge Meltem Tor; Figen Atalay
Journal:  Iran Red Crescent Med J       Date:  2015-10-28       Impact factor: 0.611

10.  Effect of bovine lactoferrin as a novel therapeutic agent in a rat model of sepsis-induced acute lung injury.

Authors:  Nannan Han; Hengjie Li; Gang Li; Ye Shen; Min Fei; Yong Nan
Journal:  AMB Express       Date:  2019-10-31       Impact factor: 3.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.